Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12556821 | 0.82 | TSHR (0.41) | GRIN1GRIN2AGRIN2DGRIN2CGRIN2B | |
| SCHEMBL6681969 | 0.79 | TAAR1 (0.54) | TAAR1MAPK1ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL1019329 | 0.78 | RIPK1 (0.52) | TAAR1MAPK1ALDH1A1ALOX15 | |
| SCHEMBL296507 | 0.77 | KCNH2 (0.48) | TAAR1ALDH1A1CYP2D6CYP3A4CYP2C19 | |
| SCHEMBL30492628 | 0.77 | KCNH2 (0.48) | TAAR1ALDH1A1CYP2D6CYP3A4CYP2C19 | |
| SCHEMBL4399833 | 0.75 | TAAR1 (0.50) | TAAR1MAPK1ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL4399836 | 0.75 | TAAR1 (0.50) | TAAR1MAPK1ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL113841 | 0.75 | TAAR1 (0.50) | TAAR1MAPK1ALDH1A1ALOX15CYP2D6 | |
| SCHEMBL10831632 | 0.75 | TAAR1 (0.56) | TAAR1 | |
| SCHEMBL28548676 | 0.74 | ALDH1A1 (0.38) | ALDH1A1ALOX15CYP2D6CYP2C19KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170050935-A1 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050935-A1 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES | RCE1, ECE1, UBE2E1 | TAAR1 4461/4885MAPK1 1662/4885ALDH1A1 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.